Authors: HARVIE P OMAR RF DUSSERRE N DESORMEAUX A GOURDE P TREMBLAY M BEAUCHAMP D BERGERON MG

Citation: P. Harvie et al., ANTIVIRAL EFFICACY AND TOXICITY OF RIBAVIRIN IN MURINE ACQUIRED-IMMUNODEFICIENCY-SYNDROME MODEL, Journal of acquired immune deficiency syndromes and human retrovirology, 12(5), 1996, pp. 451-461

Authors: HARVIE P OMAR RF DUSSERRE N LANSAC N DESORMEAUX A GOURDE P SIMARD M TREMBLAY M BEAUCHAMP D BERGERON MG

Citation: P. Harvie et al., RIBAVIRIN POTENTIATES THE EFFICACY AND TOXICITY OF 2',3'-DIDEOXYINOSINE IN THE MURINE ACQUIRED-IMMUNODEFICIENCY-SYNDROME MODEL, The Journal of pharmacology and experimental therapeutics, 279(2), 1996, pp. 1009-1017

Authors: DUSSERRE N LESSARD C BEAUCHAMP D DESORMEAUX A POULIN L TREMBLAY M BERGERON MG

Citation: N. Dusserre et al., LIPOSOMAL ENCAPSULATION DELIVERS FOSCARNET (PFA) TO SITES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) AND CYTOMEGALOVIRUS (CMV) INFECTIONS AND IMPROVES ITS PHARMACOKINETICS, Journal of cellular biochemistry, 1995, pp. 177-177

Authors: DUSSERRE N LESSARD C PAQUETTE N PERRON S POULIN L TREMBLAY M BEAUCHAMP D DESORMEAUX A BERGERON MG

Citation: N. Dusserre et al., ENCAPSULATION OF FOSCARNET IN LIPOSOMES MODIFIES DRUG INTRACELLULAR ACCUMULATION, IN-VITRO ANTI-HIV-1 ACTIVITY, TISSUE DISTRIBUTION AND PHARMACOKINETICS, AIDS, 9(8), 1995, pp. 833-841

Authors: OMAR RF DUSSERRE N DESORMEAUX A POULIN L TREMBLAY M BEAUCHAMP D BERGERON MG

Citation: Rf. Omar et al., LIPOSOMAL ENCAPSULATION OF FOSCARNET PROTECTS AGAINST HYPOCALCEMIA INDUCED BY FREE FOSCARNET, Antimicrobial agents and chemotherapy, 39(9), 1995, pp. 1973-1978